← Leaderboards
Smita K Nair
Duke University
$1,645,249
Attributed
$3,117,961
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $402.5K · FY2018–25$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,117,961 · 2
By mechanism
R01$2,945,425 · 1
P01$172,536 · 1
Top collaborators
- Matthias Gromeier8 shared
Most similar at Duke University
Same institution · by research overlap
- Matthias Gromeier$11,871,021
- Darell D Bigner$25,397,506
- Tatiana Segura$14,175,920
- Michael Barry Kastan$65,974,699
- John H Sampson$43,413,436
Others in their field
Top investigators on “Dendritic Cells”
- Barton F Haynes · Duke University$112,608,041
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- James C. Paulson · Scripps Research Institute$41,568,802
- Ulrich H Von Andrian · Harvard Medical School$32,521,007
- Donald L Morton · John Wayne Cancer Institute$29,042,629
Research focus
Dendritic CellsInvestigationDoseInfectionInflammatory ResponseInterferon Type IEngineeringHeterogeneityImmune Checkpoint BlockadeImmunotherapyAutomobile DrivingInflammatoryInsightInterferonsHuman PoliovirusCellsGlioblastomaGliomaCancer ImmunotherapyImmuneImmunologicsImmunosuppressionInflammationMacrophage
Grant awards (11)
Innate Antiviral Signals for Cancer Immunotherapy$402,500
R01 · FY2025 · NS
Innate Antiviral Signals for Cancer Immunotherapy$390,425
R01 · FY2024 · NS
Innate Antiviral Signals for Cancer Immunotherapy$402,500
R01 · FY2023 · NS
Innate Antiviral Signals for Cancer Immunotherapy$350,000
R01 · FY2022 · NS
Innate Antiviral Signals for Cancer Immunotherapy$350,000
R01 · FY2021 · NS
Innate Antiviral Signals for Cancer Immunotherapy$350,000
R01 · FY2020 · NS
Innate Antiviral Signals for Cancer Immunotherapy$350,000
R01 · FY2019 · NS
Innate Antiviral Signals for Cancer Immunotherapy$350,000
R01 · FY2018 · NS
CORE--CLINICAL CELL PROCESSING$86,268
P01 · FY2002 · CA
CORE--CLINICAL CELL PROCESSING$86,268
P01 · FY2001 · CA
CORE--CLINICAL CELL PROCESSING$0
P01 · FY2000 · CA